BG · Bunge Global

72 filings

BG SEC Filings

Bunge Global - 72 total filings

Filing record · 2023–202610-K310-Q98-K60

Showing 1–50 of 72 filings

Bunge Global 8-K Report, Material Agreement (Nov 3, 2026)

Bunge Global SA (BG) has filed a Form 8-K detailing an amendment to its existing trade receivables securitization program. The primary change is an extension of the program's termination date by 364 days, pushing it to December 13, 2027. This extension indicates continued access to this financing mechanism, providing Bunge with ongoing liquidity. The amendment also permitted the merger of a Dutch originator subsidiary into another, streamlining operations within the program without altering other material terms. This report reassures investors about the stability and continuity of Bunge's funding arrangements. The securitization program, which allows Bunge to sell its trade receivables to a financial institution and commercial paper conduits, remains a key component of its working capital management. The limited recourse structure, capped at Bunge's first loss position, is also a positive factor, mitigating potential downside risk for the company.

Nov 3, 2026 8-K

Bunge Global 8-K Report, Financial Results (Oct 29, 2026)

Bunge Global SA (BG) reported its third-quarter 2026 financial results, showcasing a significant increase in profitability compared to the prior year. Diluted Earnings Per Share (EPS) from continuing operations surged to $1.64 from $0.86, with adjusted diluted EPS reaching $2.56 compared to $2.27 in Q3 2025. This performance was primarily driven by the strong execution and expanded global network within the Soybean and Softseed Processing and Refining segments. The company also highlighted progress on strategic value-creation priorities, including Viterra-related synergies and the commencement of production at a new oilseed processing line. Bunge is maintaining its full-year adjusted EPS outlook, signaling confidence in its ongoing operational and strategic initiatives despite a complex global environment characterized by geopolitical uncertainty and shifting trade flows.

Oct 29, 2026 10-Q

Bunge Global Quarterly Report for Q3 Ended Sep 30, 2026

Bunge Global SA reported a strong increase in net income attributable to shareholders for the nine months ended September 30, 2026, reaching $1,064 million, a significant rise from $721 million in the prior year period. This performance was largely driven by the integration of the Viterra acquisition, contributing to higher segment EBIT across its core processing businesses, particularly Soybean and Softseed Processing and Refining. The company also saw a substantial increase in net sales, up 50% year-over-year to $69,706 million, reflecting both higher commodity prices and the expanded operational footprint post-acquisition. Despite robust earnings, Bunge experienced a significant increase in cash used for operating activities, totaling $2,302 million for the nine months ended September 30, 2026, primarily due to working capital requirements and higher inventory levels. Total debt also increased to $16,746 million, mainly to finance the Viterra acquisition and working capital needs. Investors should monitor the company's ability to manage its increased debt levels and working capital while continuing to integrate Viterra and navigate volatile commodity markets and geopolitical risks.

Oct 29, 2026 8-K

Bunge Global 8-K Report, Executive Changes (Oct 5, 2026)

Bunge Global SA (BG) has announced a significant leadership transition in its legal department. Effective November 9, 2026, Joseph Podwika will depart from his role as Chief Legal Officer and will be succeeded by Ignacio Walker. Mr. Podwika will move into a Senior Advisor role to the CEO, continuing with the company until his retirement in November 2027. This transition involves adjustments to Mr. Podwika's compensation, including a reduced base salary and ineligibility for annual bonuses and equity awards from 2027 onwards, reflecting his new advisory capacity. Investors should note that while this marks a change in a key executive position, the company has a succession plan in place with Mr. Walker stepping into the Chief Legal Officer role. Mr. Podwika's continued involvement as a Senior Advisor may provide a period of stability and knowledge transfer. The company has also confirmed Mr. Podwika's continued participation in existing benefit and severance plans, with details available in previous SEC filings.

Oct 5, 2026 8-K

Bunge Global 8-K Report, Corporate Update (Sep 21, 2026)

Bunge Global SA (BG), through its wholly-owned subsidiaries Bunge Limited Finance Corp. (BLFC) and Bunge Finance Europe B.V. (BFE), announced the extension of three significant revolving credit facilities. These extensions are strategically important for maintaining Bunge's financial flexibility and liquidity. The agreements, reached with creditors on September 17, 2026, push out maturity dates for substantial credit lines, providing greater certainty regarding the company's short-to-medium term funding. Specifically, the $1.1 billion 364-day revolving credit agreement managed by BLFC has been extended from October 2, 2026, to October 1, 2027. Additionally, two larger facilities have seen their termination dates extended by 12 months: the $4.2 billion 5-year revolving credit agreement (BLFC) now matures on October 3, 2031, and the $3.5 billion 3-year revolving facility agreement (BFE) matures on October 3, 2029. These extensions indicate continued lender confidence and support for Bunge's ongoing operations and strategic initiatives.

Sep 21, 2026 8-K

Bunge Global 8-K Report, Executive Changes (Sep 3, 2026)

Bunge Global SA (BG) announced a planned leadership transition in its accounting department. Controller and Chief Accounting Officer (CAO) Matt Simmons intends to retire effective March 31, 2027, after a dedicated tenure with the company. This departure is amicable and not related to any disputes regarding the company's financial practices. Investors can view this as a standard succession planning event, with Mr. Simmons committed to ensuring a smooth handover of his responsibilities. To ensure continuity and leverage internal expertise, Richard James has been appointed as Mr. Simmons' successor, effective April 1, 2027. Mr. James brings over fourteen years of experience within Bunge, having held various senior financial roles including Vice President, Finance Integration and Transformation, and Corporate Controller. His extensive background, coupled with his professional certifications (CPA, CPA Canada, CA England & Wales, CIA), positions him well to lead the company's accounting and financial reporting functions. The company has also included a Cover Page Interactive Data File as an exhibit.

Sep 3, 2026 8-K

Bunge Global 8-K Report, Corporate Update (Aug 19, 2026)

Bunge Global SA (NYSE: BG) disclosed in this Form 8-K, filed August 19, 2026, that its wholly owned finance subsidiary, Bunge Limited Finance Corp. (BLFC), completed the sale and issuance of $600 million aggregate principal amount of 5.000% Senior Notes due 2031. The notes are fully and unconditionally guaranteed by Bunge on a senior unsecured basis. Pricing was announced August 17, 2026, under an underwriting agreement with Wells Fargo Securities, BofA Securities, Mizuho Securities and Rabo Securities as representatives. The offering was made under a Form S-3 shelf registration (No. 333-282003) and the notes were issued under a September 17, 2024 base indenture as supplemented by a Fifth Supplemental Indenture dated August 19, 2026, with U.S. Bank Trust Company as trustee. Net proceeds were approximately $593.8 million after the underwriting discount and estimated offering expenses. The company states the proceeds are for general corporate purposes, which may include repaying and refinancing debt (including certain short-term indebtedness), working capital, capital expenditures, stock repurchases and investments in subsidiaries. The filing does not specify a single use of proceeds, so investors should look to the company's upcoming disclosures for allocation detail. For investors, this is a routine debt refinancing or liquidity-management transaction rather than a change in strategic direction. It adds $600 million of fixed-rate senior unsecured debt maturing in 2031, which modestly increases the company's fixed-charge burden at a 5.000% coupon, while the net proceeds offer flexibility to address near-term maturities. The filing contains no financial results, guidance, or information about the Viterra business combination beyond a forward-looking statements reference.

Aug 19, 2026 8-K

Bunge Global 8-K Report, Financial Results (Jul 29, 2026)

Bunge Global SA (NYSE: BG) reported second quarter 2026 results on July 29, 2026, with GAAP diluted EPS of $3.47 versus $2.61 a year earlier and adjusted diluted EPS of $2.00 versus $1.31. The improvement was driven mainly by Soybean Processing and Refining and Softseed Processing and Refining, which benefited from a more favorable market environment and the expanded post-Viterra footprint. Net income attributable to Bunge rose to $678 million from $354 million, and total EBIT was $1,060 million versus $538 million. Note that the GAAP quarter was flattered by $437 million of mark-to-market timing gains, which management excludes from adjusted results, so the adjusted figures are the better guide to underlying performance. Management raised its full-year 2026 adjusted EPS outlook to $9.25-$9.75 from $9.00-$9.50. Soybean Processing and Refining is now expected to be higher, Softseed slightly higher, and Grain Merchandising and Milling lower. Bunge also completed the roughly $2 billion share repurchase program tied to the Viterra transaction, buying back about $250 million of shares in the quarter. Balance-sheet and cash-flow metrics show the scale of the combined company: inventories rose to $15.5 billion, of which $13.3 billion is readily marketable inventory, total debt increased, and operating cash flow was negative $1.1 billion for the first half, though adjusted funds from operations improved to $1.29 billion from $693 million. For investors, the key questions are how much of the earnings strength is durable versus timing-related, and whether the Viterra integration delivers the expected scale benefits. Corporate costs, acquisition and integration expenses, higher interest expense ($197 million in the quarter versus $106 million), and rising working capital all warrant monitoring. The filing is furnished under Item 2.02 and is not deemed filed for Section 18 purposes.

Jul 29, 2026 10-Q

Bunge Global Quarterly Report for Q2 Ended Jun 30, 2026

Bunge Global SA reported strong financial performance for the three and six months ended June 30, 2026, with Net income attributable to Bunge shareholders increasing significantly year-over-year. This growth was primarily driven by the successful integration of the Viterra acquisition, which substantially boosted Net sales and Segment EBIT across key segments, particularly Soybean Processing and Refining and Softseed Processing and Refining. The company's strategic focus on its enhanced value chain structure is reflected in robust top-line growth, though tempered by increased interest expenses due to higher debt levels from the Viterra acquisition financing. Investors should note the positive impact of Viterra on operational scale and market position. The company also continued its share repurchase program and declared increased dividends, indicating confidence in future performance and commitment to shareholder returns.

Jul 29, 2026 8-K

Bunge Global 8-K Report, Shareholder Vote Results (May 22, 2026)

Bunge Global SA's 8-K reports the results of its 2026 Annual General Meeting, held May 20, 2026. Shareholders approved all company proposals, including the 2025 Swiss statutory financial statements, the appropriation of 2025 earnings, and a cash dividend of $2.88 per share. The dividend will be paid in four equal quarterly installments of $0.72, an increase of $0.02 per share from the prior year. This filing contains no new operating or financial results, so its investment relevance lies in shareholder income and governance signals. The dividend payments are scheduled for June 1, September 1, and December 1, 2026, and March 2, 2027, with record dates of May 22, August 18, and November 17, 2026, and February 16, 2027. Support for management and governance was generally strong. The discharge of the Board and Executive Management Team passed with about 98% of votes cast in favor, and the advisory say-on-pay vote passed with about 98% support. The auditor appointment passed with about 93% support. The main area of shareholder dissent was director elections. Chair Mark Zenuk and director Markus Walt each received roughly 89% to 92% support, the lowest levels among the nominees, and Walt received about 18 million votes against. Mark Zenuk was reelected as Board Chair, and Walt and Zenuk were also among the weaker results in the Human Resources and Compensation Committee elections. Investors may want to monitor these votes for signs of ongoing governance concerns, though all nominees were elected.

May 22, 2026 10-Q

Bunge Global Quarterly Report for Q1 Ended Mar 31, 2026

Bunge Global SA (BG) reported a net income attributable to Bunge shareholders of $68 million for the first quarter of 2026, a significant decrease from $201 million in the same period of 2025. This decline is largely attributed to lower segment EBIT and corporate EBIT, coupled with increased net interest expense resulting from higher debt levels following the Viterra acquisition. Diluted earnings per share also saw a substantial drop to $0.35 from $1.48 year-over-year. The company's net sales more than doubled to $21.86 billion from $11.64 billion, primarily driven by the inclusion of Viterra's results and strong performance across most segments, particularly Grain Merchandising and Milling and Softseed Processing and Refining. However, cost of goods sold increased proportionally, leading to a 28% rise in gross profit, which was offset by a 40% increase in selling, general, and administrative expenses. Despite the decrease in profitability, Bunge's balance sheet shows robust inventory levels and significant working capital, reflecting the expanded operational scale post-acquisition. The company maintained compliance with its financial covenants and had substantial unused committed borrowing capacity.

Apr 29, 2026 8-K

Bunge Global 8-K Report, Financial Results (Apr 29, 2026)

Bunge Global SA (NYSE: BG) reported first quarter 2026 results on April 29, 2026. GAAP diluted EPS fell to $0.35 from $1.48 a year earlier, and net income attributable to Bunge dropped to $68 million from $201 million. On an adjusted basis, which excludes mark-to-market timing differences and certain charges, EPS was $1.83 versus $1.81, roughly flat. Management attributed the operating performance to Soybean and Softseed Processing and Refining, driven by South American processing strength, expanded Argentine capacity, and a larger origination footprint following the Viterra combination. Adjusted Total EBIT rose to $561 million from $362 million, while reported Total EBIT was $184 million versus $328 million. The large gap between GAAP and adjusted figures is mainly a $336 million mark-to-market timing impact, which management says is expected to reverse over time. The company raised its full-year 2026 adjusted EPS outlook to $9.00 to $9.50 from $7.50 to $8.00. The guidance increase is offset by higher expected net interest expense of $620 to $660 million, up from $575 to $625 million, and by lower expected results in Tropical Oils and Grain Merchandising. Cash flow weakened: operating cash flow was negative $541 million, compared with negative $285 million a year ago, largely due to working capital build. Inventories rose to $15.4 billion, including $13.4 billion of readily marketable inventories, and total debt increased. Adjusted funds from operations improved to $530 million from $392 million. Investors should weigh the strong earnings guidance against rising leverage, negative operating cash flow, and the reliance on mark-to-market accounting, which makes reported earnings volatile.

Apr 29, 2026 8-K

Bunge Global 8-K Report, Material Agreement (Apr 2, 2026)

Bunge Global SA (BG) has announced an amendment to its existing trade receivables securitization program, increasing its aggregate size by $500 million to $2 billion. This strategic move enhances Bunge's liquidity and financial flexibility by expanding its access to funding through its receivables. Key changes include a reduction in the program's accordion feature, the addition of a U.S. subsidiary as a seller, and the removal of a German subsidiary. Notably, the sustainability provisions have been removed from the program. These adjustments indicate a recalibration of Bunge's financing strategy to optimize its current operational and financial needs. While the core terms remain consistent, these amendments signify an evolving approach to managing its working capital and balance sheet.

Apr 2, 2026 8-K

Bunge Global 8-K Report, Executive Changes (Apr 1, 2026)

Bunge Global SA (BG) has filed an 8-K report detailing a new Executive Integration Incentive Program approved on March 26, 2026. This program utilizes performance-based restricted stock units (PBRSUs) designed to incentivize senior officers, including the CEO and other named executive officers, to achieve cumulative run-rate cost synergy targets over a three-year period (January 1, 2026, to December 31, 2028). The program is directly linked to the ongoing integration of Viterra Limited, aiming to reward successful and accelerated synergy capture and sustained executive focus. The PBRSU awards are contingent upon the achievement of specified cost synergy targets and require continued employment through the vesting period. The Chief Executive Officer, Gregory Heckman, has been granted the largest number of PBRSUs, reflecting his leadership in this critical integration phase. This initiative underscores management's commitment to realizing the strategic benefits of the Viterra acquisition and aligning executive compensation with key integration milestones.

Apr 1, 2026 8-K

Bunge Global 8-K Report, Corporate Update (Mar 19, 2026)

On March 17, 2026, Bunge Limited Finance Corp. (BLFC), a wholly-owned finance subsidiary of Bunge Global SA (NYSE: BG), priced and issued $1.2 billion of senior unsecured notes in two tranches: $500 million of 4.800% Senior Notes due 2033 and $700 million of 5.150% Senior Notes due 2036. The notes are fully and unconditionally guaranteed by Bunge on a senior unsecured basis. The filing reports net proceeds of approximately $1.19 billion after underwriting discounts and offering expenses, and the offering was made under a Form S-3 shelf registration dated September 9, 2024. The Fourth Supplemental Indenture is dated March 19, 2026, which is also the expected closing date noted in the pricing press release. The transaction is a routine refinancing and liquidity action rather than a change in strategy. The company states the proceeds are for general corporate purposes, which may include repaying and refinancing debt (including certain short-term indebtedness), working capital, capital expenditures, stock repurchases, and investments in subsidiaries. Because the filing does not specify a particular use, investors should view the deal mainly as a balance sheet and liquidity event: it adds roughly $1.2 billion of longer-dated debt and may be used to term out short-term borrowings. The filing itself does not disclose the company's post-offering leverage or the specific allocation of proceeds. For investors, the key takeaways are the cost and tenor of the new debt and the flexibility it provides. The 4.800% and 5.150% coupons indicate the market pricing for Bunge's credit at this time, and the 2033 and 2036 maturities extend the company's debt maturity profile. Investors should check the 10-K for the year ended December 31, 2025 and subsequent filings for current leverage, debt maturities, and how management plans to use the proceeds.

Mar 19, 2026 8-K

Bunge Global 8-K Report, Corporate Update (Mar 17, 2026)

Bunge Global SA's March 17, 2026 Form 8-K is a supplemental filing, not a new transaction announcement. It provides the financial statements and pro forma information required under Item 9.01 for the acquisition of Viterra Limited, which closed on July 2, 2025. The acquisition was a stock and cash deal: Viterra shareholders received about 65.6 million Bunge shares (roughly $5.3 billion at closing) plus about $1.9 billion in cash, and the total purchase consideration, including repayment of Viterra debt, was about $10.6 billion. Sellers, including affiliates of Glencore, CPP Investment Board and BCI, owned roughly 33% of Bunge's registered shares after closing. The Viterra interim financials for the six months ended June 30, 2025 show revenue of $20.97 billion (down from $22.57 billion), a gross margin of $348 million (down from $473 million), and a net loss attributable to equity holders of $196 million, versus a $71 million profit a year earlier. The net loss was driven by $223 million of interest expense and a pre-tax loss of $183 million. Viterra's balance sheet shows total borrowings of about $8.6 billion, including $3.5 billion of revolving credit facility draws. Operating cash flow improved to $874 million, aided by a $1.6 billion reduction in inventories, while net debt was reduced by the use of cash and inventory liquidation. The pro forma statement of income for Bunge's year ended December 31, 2025 shows combined net sales of $89.5 billion and pro forma income from continuing operations attributable to Bunge shareholders of $650 million. Pro forma diluted EPS is $3.26, compared with $4.93 historically, reflecting the roughly 32.7 million new shares issued. Management notes that these figures exclude expected synergies and integration costs, and that purchase price allocations remain preliminary, with final adjustments due within one year of closing. For investors, the key takeaways are the dilution from the share issuance, the higher leverage carried over from Viterra, and the expected earnings benefit from the combined platform as synergies are realized.

Mar 17, 2026 10-K

Bunge Global Annual Report, Year Ended Dec 31, 2025

Bunge Global SA's 2025 results reflect a transformational year driven by the July 2, 2025 acquisition of Viterra, which lifted net sales to $70.3 billion (up 32% from $53.1 billion) and expanded the company's global origination, merchandising, and crushing footprint. However, profitability declined: net income attributable to Bunge shareholders fell to $816 million from $1,137 million, diluted EPS dropped to $4.91 from $7.99, and Total EBIT decreased 14% to $1,533 million. The decline was driven mainly by Corporate and Other EBIT losses of $796 million, which include a $118 million pension settlement loss, a $30 million investment impairment, the absence of a prior-year $195 million BP Bunge Bioenergia gain, and higher SG&A tied to the Viterra integration. Segment EBIT actually rose 8% to $2,329 million, led by Soybean Processing and Refining (up 40% to $1,225 million) and a $155 million gain on the sale of the North American corn milling business. The balance sheet changed materially. Total debt more than doubled to $14.05 billion from $6.24 billion, short-term debt rose sharply, and cash fell to $1.1 billion from $3.3 billion. Working capital remained solid at $9.26 billion, but the current ratio declined to 1.61 from 2.15. Operating cash flow fell to $844 million from $1,900 million, while capital expenditures rose to $1.72 billion, leaving free cash flow negative. Total shareholders' equity increased to $15.9 billion, largely because roughly 65.6 million shares were issued as Viterra consideration. Dividends were $2.80 per share for 2025, and share repurchases totaled $551 million. Management guides 2026 capex to $1.5–1.7 billion and expects Viterra integration to continue in phases over several years. Key risks for investors include leverage and refinancing needs, integration execution, commodity and mark-to-market volatility, Brazilian farmer credit exposure ($835 million outstanding), Ukraine war exposure, and tax and legal contingencies, particularly Brazilian indirect tax claims. Investors should also note that Glencore and CPP Investments together hold about 31% of registered shares and have board nomination rights, and that Swiss-law constraints on capital management and withholding taxes shape shareholder distributions.

Feb 19, 2026 8-K

Bunge Global 8-K Report, Financial Results (Feb 4, 2026)

Bunge Global SA (NYSE: BG) reported fourth-quarter and full-year 2025 results on February 4, 2026. The headline story is a sharp drop in GAAP earnings, but the underlying picture is more mixed. Full-year GAAP diluted EPS fell to $4.93 from $7.99, and adjusted EPS (excluding mark-to-market timing differences and certain gains/charges) fell to $7.57 from $9.19. Q4 GAAP EPS was $0.49 versus $4.36 a year earlier, and Q4 adjusted EPS was $1.99 versus $2.13. Segment-level results were stronger: adjusted Segment EBIT rose to $2,459 million from $2,335 million for the year, and Q4 adjusted Segment EBIT rose to $756 million from $546 million. The gap between the segment improvement and the EPS decline is driven by higher corporate costs (largely Viterra integration), higher interest expense, a $118 million pension settlement loss, and a larger share count following the Viterra combination, which lifted diluted weighted-average shares to 195 million in Q4 from 138 million. Balance sheet and cash flow indicators show increased leverage and lower cash generation. Operating cash flow fell to $844 million from $1,900 million, though Adjusted FFO rose modestly to $1,733 million from $1,682 million. Total debt rose meaningfully: short-term debt increased to $3,883 million and long-term debt to $8,831 million, while cash fell to $1,135 million from $3,311 million. Inventories grew to $13,198 million, including $11,361 million of readily marketable inventories, and goodwill and intangibles expanded to $3,450 million from $774 million. Management said forward visibility remains limited. For 2026, Bunge guided to adjusted EPS of $7.50 to $8.00, with net interest expense of $575 to $625 million, capital expenditures of $1.5 to $1.7 billion, D&A of about $975 million, and an adjusted tax rate of 23% to 27%. Management will provide more detail on long-term outlook, synergy capture, and capital allocation at its Investor Day on March 10, 2026.

Feb 4, 2026 8-K

Bunge Global 8-K Report, Bylaw Amendment (Dec 19, 2025)

Bunge Global SA (BG) has filed an 8-K report detailing an amendment to its Articles of Association, specifically Article 4, effective December 16, 2025. This amendment reflects a reduction in the company's share capital by USD 123,826.10, bringing the total share capital down to USD 2,085,117.63. This reduction is a direct consequence of the cancellation of 12,382,610 registered shares, which were previously repurchased under the company's ongoing share repurchase program. The nominal value of each repurchased share was $0.01. Following the capital reduction, Article 4a of the Articles of Association was also updated to adjust the Swiss "capital band" provision. Investors should note that this action is primarily an administrative and accounting adjustment related to share buybacks, rather than a fundamental change in the company's business operations or financial performance. The amended Articles of Association have been filed as an exhibit, providing transparency on these changes.

Dec 19, 2025 8-K

Bunge Global 8-K Report, Executive Changes (Dec 12, 2025)

Bunge Global SA (BG) has announced a leadership change, with David Mattiske stepping down as co-Chief Operating Officer, effective December 11, 2025, and separating from the company on December 31, 2025, to pursue other opportunities. Mr. Mattiske will receive severance compensation and benefits in accordance with the company's established Executive Severance Plan. Following Mr. Mattiske's departure, Julio Garros, currently co-Chief Operating Officer, will assume the sole role of Chief Operating Officer, effective December 12, 2025. This transition is designed to ensure an orderly handover of responsibilities. Investors should monitor the impact of this leadership adjustment on operational continuity and strategic execution.

Dec 12, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Dec 11, 2025)

Bunge Global SA (BG) announced on December 11, 2025, an amendment to its existing trade receivables securitization program. The primary effect of this amendment, executed via the Twenty-Ninth Amendment to the Receivables Transfer Agreement, is the extension of the program's termination date by an additional 364 days, moving it from December 2025 to December 15, 2026. This extension provides Bunge with continued access to this financing facility, which is crucial for managing its working capital and liquidity. This proactive measure by Bunge demonstrates a commitment to maintaining stable funding sources. While other terms of the securitization program remain unchanged, investors should note that the program involves customary representations, warranties, and covenants, including potential repurchase obligations for ineligible receivables and a first-loss position for Bunge as a subordinated lender. The reliance on this program for liquidity means its terms and continued availability are important considerations for evaluating Bunge's financial health.

Dec 11, 2025 10-Q

Bunge Global Quarterly Report for Q3 Ended Sep 30, 2025

Bunge Global SA (BG) reported its third-quarter and nine-month results for the period ending September 30, 2025. The company's net income attributable to Bunge shareholders for the third quarter decreased to $166 million from $221 million in the prior year, largely due to higher net interest expense from increased debt levels following the Viterra acquisition and lower Corporate and Other EBIT. However, for the nine-month period, net income increased to $721 million from $535 million, driven by higher segment EBIT. This quarter marks the first reporting period to significantly include the results of the recently acquired Viterra, significantly impacting various financial metrics and segment reporting. The company's balance sheet shows a substantial increase in total assets to $46.3 billion from $24.9 billion at year-end 2024, primarily reflecting the Viterra acquisition. Total debt also saw a significant rise, reaching $15.6 billion compared to $6.2 billion at year-end 2024. Despite increased debt, the company maintained compliance with its financial covenants. The company also completed several strategic divestitures and acquisitions, including the sale of its North American corn milling business and the EU Oilseeds divestment as a condition of the Viterra acquisition, alongside smaller acquisitions.

Nov 5, 2025 8-K

Bunge Global 8-K Report, Financial Results (Nov 5, 2025)

Bunge Global SA's Q3 2025 results, filed November 5, 2025, show a company in its first full quarter after closing the Viterra combination. Q3 GAAP diluted EPS from continuing operations was $0.86, down from $1.56 a year earlier, but adjusted EPS was $2.27 versus $2.29, roughly flat. The gap between GAAP and adjusted figures is mainly mark-to-market timing differences ($0.87 per share in the quarter) and acquisition and integration costs ($0.54 per share). Adjusted Total EBIT rose to $757 million from $491 million, driven by Soybean and Softseed Processing and Refining, which benefited from the added Viterra assets, higher margins, and Argentine capacity. Nine-month results were supported by a $155 million gain on the sale of the North American corn milling business. Balance sheet and cash flow changed sharply. Total assets rose to $46.3 billion from $24.9 billion at year-end 2024, and total debt (short-term debt, current portion, and long-term debt) reached roughly $15.6 billion. Operating cash flow was negative $503 million for the nine months, versus positive $847 million a year earlier, mainly due to working capital build. Inventories include $11.5 billion of readily marketable inventories. Adjusted funds from operations were $1.18 billion, down from $1.28 billion. Bunge repurchased $545 million of shares in the nine months and reaffirmed full-year 2025 adjusted EPS guidance of $7.30 to $7.60. That guidance implies second-half adjusted EPS of $4.00 to $4.25, well below the first nine months, which is the key forward-looking point for investors. The filing is furnished under Item 2.02 rather than filed, so the press release content is not subject to Section 18 liability. Investors should weigh the strong operating momentum and reaffirmed guidance against higher leverage, the negative operating cash flow, the large mark-to-market swings, and ongoing integration costs.

Nov 5, 2025 8-K

Bunge Global 8-K Report, Regulation FD Disclosure (Oct 15, 2025)

Bunge Global SA (BG) filed an 8-K on October 15, 2025 furnishing a press release that changes its segment and volume reporting to reflect the combined company after the July 2, 2025 closing of its combination with Viterra Limited. Beginning with Q3 2025, Bunge will report four reportable segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling, plus Corporate and Other. Volume reporting is also enhanced to track oilseeds processed, oilseeds merchandised, and refined oil production, aligned with the company's income-generating activities. Prior-period figures for 2024 and the first two quarters of 2025 have been recast. These changes do not affect previously reported consolidated financial statements. The most important investor item is the recast full-year 2025 adjusted EPS outlook of approximately $7.30 to $7.60, down from the prior ~$7.75 outlook given on July 30, 2025. That prior figure excluded Viterra, so the lower range reflects the inclusion of Viterra's shares and earnings, net of buybacks through Q3, rather than a straightforward operating deterioration. The outlook implies second-half adjusted EPS of $4.00 to $4.25, which is a meaningful step down from the first half and reflects management's view of margin and macro conditions, including the impact on Q4. The recast historical data shows how the new structure reshapes the earnings mix. For example, Soybean Processing and Refining generated $1,229 million of adjusted EBIT in FY2024, versus $565 million for Softseed and $364 million for Grain Merchandising and Milling. Q2 2025 adjusted Segment EBIT was $373 million, with Softseed falling to $14 million from $82 million in Q1. Investors should note that the segment structure is still new, and the full detail and drivers of the outlook will come with the Q3 2025 earnings release on November 5, 2025.

Oct 15, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Oct 8, 2025)

Bunge Global SA (BG), through its subsidiaries Bunge Limited Finance Corp. (BLFC) and Bunge Finance Europe B.V. (BFE), has significantly restructured and expanded its credit facilities. This 8-K filing details the entry into new, larger credit agreements totaling over $9.6 billion in potential revolving credit, replacing older agreements. Key among these is a $4.2 billion 5-year revolving credit facility for BLFC and a $3.5 billion 3-year revolving credit facility for BFE, both allowing for potential increases via accordion provisions. Additionally, a $1.1 billion 364-day revolving credit facility for BLFC and an amended CoBank Credit Facility are in place, offering further liquidity. These new facilities provide substantial financial flexibility for general corporate purposes and indicate a proactive approach to managing the company's liquidity and capital structure.

Oct 8, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Sep 9, 2025)

Bunge Global SA (BG) announced through its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), a significant increase in its unsecured corporate commercial paper program. The aggregate size of the BLFC CP Program has been expanded by $1.0 billion, raising the total available amount from $2.0 billion to $3.0 billion. This strategic move provides Bunge with enhanced financial flexibility and increased access to short-term funding to support its ongoing operations and strategic initiatives. Bunge Global SA acts as the guarantor for all notes issued under this program, underscoring its commitment to the program's obligations.

Sep 9, 2025 10-Q

Bunge Global Quarterly Report for Q2 Ended Jun 30, 2025

Bunge Global SA (BG) reported a significant increase in net income attributable to shareholders for the six months ended June 30, 2025, reaching $555 million compared to $314 million in the prior year period. This growth was driven by a substantial improvement in segment EBIT, particularly in the Agribusiness segment, which saw a 56% increase year-over-year, and the Milling segment, up 175%. The company also reported a notable gain on the sale of its North America corn milling business. A key event during the period was the completion of the Viterra acquisition on July 2, 2025. This transformative acquisition is expected to create a premier global agribusiness solutions company. In preparation for this acquisition, Bunge significantly increased its debt levels, leading to a substantial rise in total debt to $11.27 billion as of June 30, 2025, from $6.24 billion at the end of 2024. Despite the increased leverage, the company's working capital also improved considerably.

Aug 5, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Aug 4, 2025)

On July 31, 2025, Bunge Limited Finance Corp. (BLFC), a wholly-owned finance subsidiary of Bunge Global SA (NYSE: BG), priced and sold $1.3 billion of senior unsecured notes in two equal tranches: $650 million of 4.550% Senior Notes due 2030 and $650 million of 5.150% Senior Notes due 2035. The notes are fully and unconditionally guaranteed by Bunge Global SA on a senior unsecured basis. The offering was made under a Form S-3 shelf registration statement dated September 9, 2024, and the filing reports net proceeds of approximately $1.29 billion after underwriting discounts and estimated fees. The 8-K reflects the closing of the transaction, with the Third Supplemental Indenture dated August 4, 2025, and related legal opinions and underwriting documents filed as exhibits. For investors, the key takeaway is that this is a routine-looking but meaningful debt financing that adds roughly $1.3 billion of long-term debt, extending Bunge's maturity profile out to 2030 and 2035. The company states the proceeds are for general corporate purposes, which explicitly include repaying and refinancing debt (including certain short-term borrowings), working capital, capital expenditures, stock repurchases, and investments in subsidiaries. The filing does not specify the allocation among these uses, so investors should look to subsequent disclosures for how the proceeds are deployed and how the new debt affects leverage and interest expense. The 8-K does not disclose quarterly results, guidance, or changes to operations. The coupon rates of 4.550% and 5.150% provide a reference point for Bunge's current borrowing costs at the time of pricing. Because the notes are guaranteed by the parent, credit exposure sits at the Bunge Global SA level, and the 2030 and 2035 maturities will be relevant to future refinancing planning.

Aug 4, 2025 8-K

Bunge Global 8-K Report, Financial Results (Jul 30, 2025)

Bunge Global SA (BG) reported Q2 2025 results on July 30, 2025 that were better than management expected but weaker than a year ago on an adjusted basis. GAAP diluted EPS was $2.61 versus $0.48 in the prior-year quarter, but this was inflated by a $155 million pre-tax gain on the sale of its North American corn milling business. Adjusted diluted EPS fell to $1.31 from $1.73, and adjusted Total EBIT dropped to $293 million from $405 million. Agribusiness was the bright spot, with Processing EBIT rising in South America and Asia, though Refined and Specialty Oils declined in all regions on softer energy demand tied to policy uncertainty. The quarter also marked the completion of the transformative Viterra combination, which closed on July 2, 2025, after the period end. Management kept its adjusted full-year 2025 EPS outlook at approximately $7.75, but this figure excludes Viterra and no longer includes corn milling earnings for the second half. Management said it expects to provide a forecast for the combined company before reporting third-quarter results. Investors should weigh the strategic upside of Viterra's scale against near-term integration costs, higher leverage, and the lack of a combined-company guidance update. Balance sheet and cash flow data point to a heavier financing and working-capital position. Cash and equivalents rose to $6.79 billion, but short-term debt climbed to $3.54 billion and long-term debt to $7.04 billion, against $875 million and $4.69 billion at year-end 2024. Operating cash flow was negative $1.36 billion for the first half, driven mainly by working capital, and Adjusted FFO fell to $693 million from $895 million. Much of the cash build reflects borrowings and the $206 million sale of a redeemable noncontrolling interest, so underlying cash generation should be monitored as the combined company is integrated.

Jul 30, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Jul 8, 2025)

Bunge Global SA (BG), through its wholly-owned subsidiary Bunge Limited Finance Corp. (BLFC), has successfully completed its previously announced exchange offers and consent solicitations. This transaction involved exchanging outstanding Viterra Finance B.V. (VFBV) notes for new notes issued by BLFC, guaranteed by Bunge, and in some cases, cash. The primary objective was to simplify Bunge's debt structure and eliminate certain covenants and restrictive provisions associated with the Viterra debt. Investors should note that a significant portion of the Viterra notes were exchanged, with BLFC issuing approximately $1.95 billion in new aggregate principal amount of notes across four maturity dates (2026, 2027, 2031, and 2032). These new Bunge notes carry the same coupon rates as the Viterra notes they replaced. While the majority of Viterra's debt has been refinanced under Bunge's structure, a small principal amount of the original Viterra notes remains outstanding, subject to their existing terms as amended. Bunge has also entered into a registration rights agreement to facilitate the future registration of these new notes.

Jul 8, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Jul 7, 2025)

On July 7, 2025, Bunge Global SA (NYSE: BG) announced the expiration and final results of exchange offers and consent solicitations run by its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), for four series of notes originally issued by Viterra Finance B.V. (2.000% due 2026, 4.900% due 2027, 3.200% due 2031 and 5.250% due 2032). The exchange offers expired July 3, 2025, and holders tendered 96.6% to 99.9% of each series, with the 2026 notes at 96.63%, the 2027 notes at 97.72%, the 2031 notes at 99.77% and the 2032 notes at 99.93%. Holders exchanged into new Bunge-guaranteed notes of up to $1.95 billion in aggregate principal, plus cash. The transaction is a consequence of Bunge's completed acquisition of Viterra, which closed on July 2, 2025 and was a condition of the offers. The consents already received in September 2024 authorize amendments that strip most covenants, restrictive provisions and events of default from the legacy Viterra notes, and release the parent guarantees of Viterra Limited and Viterra B.V. These amendments become operative only at settlement, which is expected on July 8, 2025. Once settled, the remaining legacy Viterra debt will be effectively consolidated into Bunge's own credit structure, with Bunge as the guarantor of the new notes and the Viterra guarantees removed. For investors, the filing is primarily a debt-refinancing and simplification event rather than a change in operating results. The very high participation rates indicate broad holder acceptance of the exchange terms, which reduces the legacy Viterra debt stack and its separate guarantee structure. The principal risks lie in execution and in the ultimate size of the new Bunge-guaranteed obligations, which add to Bunge's consolidated debt load. The filing does not disclose updated financial results or guidance, so the assessment depends on Bunge's broader leverage and cash flow profile after the Viterra integration.

Jul 7, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Jul 2, 2025)

On July 2, 2025, Bunge Global SA (NYSE: BG) completed its acquisition of Viterra Limited, a privately held Jersey-incorporated agribusiness, creating a combined global agribusiness platform. Bunge acquired all Viterra shares from the Sellers (Glencore, CPP Investments, BCI and the Viterra Employee Benefit Trust) by issuing approximately 65.6 million registered shares valued at about $5.3 billion and paying approximately $2.0 billion in cash. The Sellers, excluding the Viterra EBT, now collectively own roughly 33% of Bunge's registered shares, a significant change in the shareholder base. Bunge withheld $150 million of cash consideration pending agreement on Danube Leakage calculations, and the cash portion was funded from cash on hand and existing debt instruments. The filing also documents governance and shareholder arrangements tied to the closing, including Shareholder's Agreements with Glencore and CPPIB, a Registration Rights Agreement, and a BCI lock-up agreement. Four Board members nominated by CPPIB and Glencore take their seats upon closing, and David Mattiske, Viterra's former CEO, joined as Co-Chief Operating Officer alongside Julio Garros. Exhibit 99.4 indicates Bunge drew $2.3 billion of an $8.0 billion acquisition financing package on June 30, 2025 and used proceeds from senior notes and cash to repay a portion of Viterra's debt. Pro forma figures show Q1 2025 pro forma net income attributable to Bunge of $63 million ($0.31 per diluted share) versus a 2024 pro forma figure of $1,168 million ($5.62 per diluted share), reflecting the larger share count, purchase accounting, and financing effects. Investors should weigh the meaningful dilution and ownership concentration against the expected scale, diversification and synergy benefits, which management has not quantified in this filing. The pro forma statements are preliminary and subject to change as purchase price allocation is finalized within one year, so the goodwill of roughly $2.1 billion and fair-value adjustments may shift materially. The combined company's leverage has also increased substantially, given that Bunge assumed or repaid large Viterra debt balances and drew new acquisition financing.

Jul 2, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Jun 30, 2025)

Bunge Global SA (BG) announced a significant financing event through its wholly owned subsidiary, Bunge Limited Finance Corp. (BLFC), which entered into a $2 billion Term Loan Agreement. This substantial debt facility is specifically earmarked to fund the acquisition of Viterra Limited (Viterra), a transaction expected to reshape Bunge's operational footprint and market position. The proceeds will also cover a portion of Viterra's existing debt and associated transaction costs, underscoring the comprehensive financial strategy behind this major acquisition. The loan carries a maturity date of June 1, 2028, and interest will be tied to SOFR or an alternate base rate plus an applicable margin. This financing is a critical step in the execution of Bunge's Viterra acquisition strategy. Investors should monitor the integration of Viterra and the impact of this new debt on Bunge's leverage ratios and financial flexibility. The agreement includes standard covenants and events of default, and Bunge Global SA has provided a corporate guaranty for the obligations of BLFC, signaling the parent company's commitment to this financing. The details of this agreement, along with the Guaranty, are crucial for understanding the financial implications of the Viterra acquisition.

Jun 30, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Jun 16, 2025)

Bunge Global SA (BG) has filed an 8-K reporting on significant amendments to its revolving credit facilities through its subsidiaries Bunge Limited Finance Corp. (BLFC) and Bunge Finance Europe B.V. (BFE). These amendments primarily relate to increasing the available borrowing capacity under these facilities, with a substantial portion of the increased commitments contingent upon the approval of Bunge's acquisition of Viterra Limited by applicable governmental authorities. This strategic move enhances Bunge's financial flexibility and liquidity, positioning the company to manage its operations and potential integration costs associated with the Viterra acquisition. Specifically, the BLFC credit agreement has been amended to allow for $1.95 billion in existing commitments and an additional $1.25 billion in incremental commitments, totaling up to $3.2 billion. The BFE European facility has also been amended to increase its total commitments to $3.5 billion, including $1.75 billion in additional commitments. The parent company, Bunge, provides guarantees for these credit facilities, underscoring the integrated nature of its financial operations. Investors should monitor the progress of the Viterra acquisition approval, as it directly impacts the full availability of these enhanced credit lines.

Jun 16, 2025 8-K

Bunge Global 8-K Report, Material Agreement (Jun 13, 2025)

Bunge Global SA (BG) has filed an 8-K report on June 13, 2025, announcing significant progress towards the closing of its previously announced acquisition. The company, along with the Designated Sellers (Glencore, CPPIB, and BCI), have entered into an amendment to the Business Combination Agreement. This amendment sets a new Closing Date for the Transactions, including the Acquisition, as July 2, 2025, and extends the Extended Outside Date to July 3, 2025. Crucially, certain conditions to closing have been waived or deemed satisfied, and Bunge has waived its right to terminate the agreement under specific circumstances, signaling a strong commitment to finalizing the deal. Furthermore, Bunge announced that it has received the necessary antitrust and foreign direct investment approvals from the State Administration for Market Regulation of the People’s Republic of China and the Federal Economic Competition Commission of the United Mexican States. With these key regulatory hurdles cleared, and subject to the satisfaction of any remaining conditions as modified by the amendment, Bunge and the Sellers anticipate consummating the acquisition on July 2, 2025. This filing provides greater certainty for investors regarding the near-term completion of this transformative transaction.

Jun 13, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Jun 12, 2025)

Bunge Global SA (NYSE: BG) disclosed that its subsidiary Bunge Limited Finance Corp. (BLFC) extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V. (Viterra notes). The deadline moved from 5:00 p.m. NYC time on June 13, 2025 to 5:00 p.m. NYC time on July 3, 2025, and BLFC has said it will extend again if the Viterra acquisition cannot close by the expiration date. The offers allow holders to exchange the Viterra notes for up to $1.95 billion of new BLFC notes guaranteed by Bunge, plus cash. The consent solicitations seek to strip most covenants and events of default from the existing Viterra indentures and release the Viterra and Viterra B.V. guarantees. The supplemental indentures were executed on September 23, 2024, but the amendments take effect only at settlement, which is expected within two business days after expiration. Participation is high. As of 5:00 a.m. NYC time on June 12, 2025, about $1.89 billion of the $1.95 billion outstanding principal (roughly 97%) had been validly tendered and not withdrawn, with series-level rates ranging from 95.7% to 99.4%. Because the exchange offers depend on the Viterra acquisition, the timing of settlement is tied to deal closing. Bunge said the regulatory approval process was progressing and that it expected to close the acquisition 'in the next several months.' The offers are not conditioned on financing, and the Business Combination is conditioned on antitrust approvals and other customary closing conditions. For investors, the filing shows Bunge's plan to consolidate Viterra's debt into its own credit, with Bunge guaranteeing the new notes and Viterra's guarantees removed. This is a debt-management step tied to the acquisition rather than a new operating disclosure. Holders who do not tender will keep notes with weaker covenant protection and likely reduced liquidity, as the press release warns. The filing reflects conditions as of June 12, 2025, so investors should check later filings for the current status of the acquisition and the offers.

Jun 12, 2025 8-K

Bunge Global 8-K Report, Shareholder Vote Results (May 19, 2025)

Bunge Global SA's 2025 Annual General Meeting, held May 15, 2025, approved every proposal on the agenda. Shareholders approved the 2024 Swiss statutory financial statements, the appropriation of the 2024 accumulated loss, and a cash dividend of $2.80 per share, payable in four equal $0.70 installments from the reserve from capital contributions. The first installment is payable June 2, 2025 to holders of record on May 19, 2025, with the remaining three paid in September and December 2025 and March 2026. For investors, the dividend schedule is the most concrete item, and it signals that management and shareholders are maintaining the distribution. Governance results were broadly supportive, but several votes show notable shareholder dissent. The advisory say-on-pay vote on named executive officer compensation drew about 15% against (15.4 million votes against versus 84.6 million for), and the advisory vote on the Swiss Compensation Report drew about 4.7% against. Carol Browner received roughly 7.3% against her re-election as director, and the ratification of the independent auditor drew about 6.3 million votes against. Linda Jojo, a former United Airlines executive with technology and cybersecurity experience, was elected to the Board for a term ending at the 2026 AGM. Shareholders also approved four director appointments (Anne Jensen, Adrian Isman, Christopher Mahoney and Markus Walt) that are contingent on the closing of the Viterra Limited business combination, along with related shareholder agreements with CPP Investments and Glencore. The filing is largely procedural, with no new financial results or guidance. Its main significance is confirming the dividend and governance slate, and the Viterra-contingent board appointments are a forward-looking marker of the pending transaction's structure. Investors should watch the closing of the Viterra deal and the board changes that follow it, as well as the level of dissent on compensation.

May 19, 2025 10-Q

Bunge Global Quarterly Report for Q1 Ended Mar 31, 2025

Bunge Global SA (BG) reported net income attributable to Bunge shareholders of $201 million for the first quarter of 2025, a decrease from $244 million in the same period of 2024. Diluted earnings per share also declined to $1.48 from $1.68 year-over-year. This decline was primarily driven by lower segment EBIT, particularly in the Refined and Specialty Oils segment, which experienced reduced gross profit. Despite the decrease in net income, Bunge's total assets grew to $26.66 billion, and the company maintained a healthy working capital position of $8.84 billion. The company is progressing with its significant Viterra acquisition, having secured substantial financing and reduced acquisition financing commitments following divestitures. Bunge's operational performance reflects mixed segment results. The Agribusiness segment saw a 3% decrease in EBIT, largely due to lower gross profit in its merchandising and processing operations, impacted by price stabilization and supply/demand dynamics. The Refined and Specialty Oils segment experienced a significant 49% drop in EBIT, primarily due to lower margins in North America. The Milling segment's EBIT also decreased by 45% due to pressured milling margins. On a positive note, Corporate and Other EBIT improved significantly due to lower acquisition and integration costs related to the Viterra deal. The company's liquidity remains strong with substantial unused committed borrowing capacity.

May 7, 2025 8-K

Bunge Global 8-K Report, Financial Results (May 7, 2025)

Bunge Global SA (NYSE: BG) reported first quarter 2025 results on May 7, 2025, with earnings down sharply year over year. GAAP diluted EPS was $1.48 versus $1.68 a year earlier, and adjusted diluted EPS (excluding mark-to-market timing differences and certain charges) was $1.81 versus $3.04. Total EBIT fell to $328 million from $433 million, and adjusted Total EBIT fell to $362 million from $676 million. The decline was driven mainly by lower Agribusiness results, particularly in Processing (adjusted Processing EBIT of $207 million versus $411 million), and by a more balanced supply and demand environment in Refined and Specialty Oils, where adjusted Segment EBIT was $123 million versus $204 million a year earlier. Milling and Corporate results were comparatively steadier, and lower corporate expenses partly offset the weakness. Cash flow was a notable weak point. Cash used in operating activities was $285 million, compared with $994 million of cash provided a year earlier, mainly because of working capital build. Inventories rose to $7.8 billion, including $6.5 billion of readily marketable inventories, and adjusted funds from operations fell to $392 million from $514 million. Net debt-related items also shifted, with short-term debt rising to $1.33 billion. Management attributed part of the first-quarter strength to tariff-related timing shifts in demand and farmer activity. Management maintained its full-year 2025 adjusted EPS outlook of approximately $7.75, although the Agribusiness outlook was trimmed slightly. Interest expense guidance was lowered to $220 to $250 million, and the company is in the final regulatory stage of its pending Viterra combination, which it says it is prepared to close quickly. The company also agreed to divest its European margarine and U.S. corn milling businesses. Investors will want to watch the Viterra closing timeline, the reversal of the working capital build, and whether the full-year EPS target holds given the weaker first-quarter run rate.

May 7, 2025 8-K

Bunge Global 8-K Report, Corporate Update (May 2, 2025)

On May 2, 2025, Bunge Global SA (NYSE: BG) announced that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), further extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V. (2026, 2027, 2031 and 2032 notes, totaling roughly $1.95 billion of eligible principal). The expiration moved from May 5, 2025 to June 13, 2025, and may be extended further. These exchange offers are tied to Bunge's pending acquisition of Viterra, and BLFC indicates it will keep extending the deadline until the deal can close on or before the expiration date. Bunge stated that the regulatory approval process is progressing and that it expects to close in the next several months. As of 5:00 a.m. on May 2, 2025, holders had validly tendered roughly 96% to 99% of each series: about $576.7 million of the 2026 notes (96.1%), $430.6 million of the 2027 notes (95.7%), $596.4 million of the 2031 notes (99.4%), and $288.2 million of the 2032 notes (96.1%). Consents from the September 2024 early deadline were sufficient to approve the proposed amendments, which would strip many covenants and events of default and release the Viterra and Viterra B.V. guarantees. Those amendments become operative only at settlement, which is expected within two business days after the expiration date. For investors, the filing is mainly a procedural update, but it signals that the Viterra acquisition timeline has slipped beyond the original schedule. The high tender rates suggest broad holder participation, and the consent-based changes will reduce protections for any Viterra notes that remain outstanding, which may reduce their liquidity. The filing does not disclose a new closing date, so investors should watch for antitrust approvals and further extension notices.

May 2, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Apr 4, 2025)

Bunge Limited Finance Corp. (BLFC), a wholly-owned subsidiary of Bunge Global SA (NYSE: BG), has further extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V. The expiration moves from April 7, 2025 to May 5, 2025, unless further extended. The offers cover the 2.000% notes due 2026, 4.900% notes due 2027, 3.200% notes due 2031 and 5.250% notes due 2032, in exchange for up to $1.95 billion of new BLFC notes guaranteed by Bunge, plus cash. The exchange is tied to Bunge's pending acquisition of Viterra, and the offers are conditioned on that deal closing. The consent solicitations seek to strip most covenants, restrictive provisions and events of default from the existing Viterra indentures, and to release the Viterra and Viterra B.V. guarantees. Supplemental indentures reflecting these changes were executed on September 23, 2024, but they only become operative at settlement. Settlement is expected within two business days after the expiration date. Participation is strong: as of 5:00 a.m. on April 4, 2025, between 96.1% and 99.1% of each series had been tendered. Bunge also says the regulatory approval process is progressing and it expects to close the Viterra acquisition within the next several months. If the deal is not expected to close by May 5, the company anticipates further extensions. For investors, the filing is mainly procedural, but it signals that Bunge is close to completing the Viterra transaction and restructuring Viterra's debt. The high tender rates point to broad creditor support for the exchange. The main consequence for remaining holders is reduced liquidity and weaker protection, since the amendments remove covenants and guarantees from the Viterra notes that are not exchanged.

Apr 4, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Mar 6, 2025)

On March 6, 2025, Bunge Global SA (NYSE: BG) announced that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), further extended the expiration date of its exchange offers and consent solicitations for four series of Viterra Finance B.V. notes (2026, 2027, 2031 and 2032 maturities, totaling roughly $1.95 billion of eligible exchange capacity) from March 7, 2025 to April 7, 2025, unless further extended. The exchange offers allow holders to exchange existing Viterra notes for new BLFC notes guaranteed by Bunge, or receive cash, and the accompanying consent solicitations seek to strip covenants and events of default from the Viterra indentures and release the Viterra and Viterra B.V. guarantees. The Proposed Amendments were already approved by sufficient consents in September 2024 and supplemental indentures were executed on September 23, 2024, but they become operative only at settlement, expected within two business days after the expiration date. The transaction is tied to Bunge's pending acquisition of Viterra. Completion of the exchange offers is conditioned on closing the Business Combination, which in turn depends on antitrust approvals and other customary conditions. Bunge stated that the regulatory process is progressing and it expects to close the deal in the next several months. If the deal is not expected to close by the expiration date, BLFC plans to keep extending the offers until closing is feasible, with advance notice to holders. For investors, the key takeaways are the high participation rates to date (roughly 96% to 99% of each series tendered as of 5:00 a.m. on March 6, 2025) and the implications for remaining Viterra noteholders. Holders who do not exchange face reduced liquidity in their notes and weaker protections once the covenants are removed. For Bunge, the filing is a routine procedural step in its capital structure consolidation, but the extension highlights that timing depends on regulatory approvals that remain outstanding.

Mar 6, 2025 10-K

Bunge Global Annual Report, Year Ended Dec 31, 2024

Bunge Global SA's FY2024 10-K shows a sharp earnings reset: net income attributable to Bunge shareholders fell to $1,137 million (diluted EPS $7.99) from $2,243 million ($14.87) in 2023, driven mainly by lower Core Segment EBIT ($2,171 million vs. $3,717 million). Total EBIT declined to $1,792 million from $3,333 million. Net sales fell 11% to $53.1 billion, with Agribusiness gross profit down 42% and Refined and Specialty Oils and Milling results mixed. Operating cash flow dropped to $1,900 million from $3,308 million. Corporate and Other EBIT worsened to a $594 million loss, largely due to $244 million of Viterra acquisition and integration costs, though a $195 million gain on the sale of the BP Bunge Bioenergia stake partially offset weakness in the core business. The balance sheet remains solid: working capital was $8.5 billion, the current ratio was 2.15, and cash rose to $3.3 billion. Total debt increased to $6.2 billion from $4.9 billion after $2.0 billion of senior notes were issued to fund the Viterra deal. Management expects total debt to rise to about $13 billion at closing, and credit ratings are on positive watch (S&P CreditWatch Positive, with a possible upgrade to A-). Shareholders received $1.1 billion in buybacks and about $373 million in dividends, and the company has about $800 million of repurchase authorization remaining. The dominant forward-looking item is the pending acquisition of Viterra, which would add roughly 65.6 million registered shares (about $5.1 billion at year-end 2024 prices) plus about $2.0 billion in cash, leaving Viterra's former owners with about 30% of the combined company. Closing depends on remaining antitrust clearances, and the termination date was extended to March 13, 2025, with a further extension to June 13, 2025 possible. A $400 million break fee applies if the deal fails on antitrust grounds. Investors should weigh the earnings decline, rising leverage, and integration execution risk against the strategic scale the transaction would create.

Feb 20, 2025 8-K

Bunge Global 8-K Report, Financial Results (Feb 5, 2025)

Bunge Global SA (NYSE: BG) reported fourth-quarter and full-year 2024 results on February 5, 2025, with a clear earnings decline. Full-year GAAP diluted EPS fell to $7.99 from $14.87, and adjusted EPS (excluding mark-to-market timing differences and certain gains/charges) fell to $9.19 from $13.66. Q4 GAAP diluted EPS was $4.36 versus $4.18, but adjusted Q4 EPS dropped to $2.13 from $3.70. Core Segment EBIT declined to $2.17 billion from $3.72 billion for the year, driven mainly by lower Agribusiness Processing results in North America and lower Refined and Specialty Oils results, particularly in North America. Management attributed the weakness to a more balanced supply-demand environment and uncertainty around U.S. biofuel policy, and acknowledged that results did not meet its expectations. Balance sheet and cash flow showed pressure. Operating cash flow fell to $1.9 billion from $3.3 billion, and adjusted funds from operations declined to $1.68 billion from $2.47 billion. Bunge still repurchased $1.1 billion of shares for the year, including $500 million in Q4, and ended the year with $3.3 billion in cash. Gross debt rose, with long-term debt increasing to $4.69 billion from $4.08 billion, and total equity declined. Non-core results were supported by a $195 million one-time gain from the sale of its 50% stake in the BP Bunge Bioenergia sugar and bioenergy joint venture, completed October 1, 2024. Looking ahead, Bunge forecast full-year 2025 adjusted EPS of approximately $7.75, below 2024 adjusted EPS of $9.19, and guided to lower Agribusiness and Refined and Specialty Oils results, with Milling and Corporate and Other expected to improve. The outlook excludes announced acquisitions, notably the pending Viterra combination, which management said is in late stages of regulatory approval and expected to close soon. Forward visibility was described as limited given heightened geopolitical uncertainty.

Feb 5, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Jan 31, 2025)

On January 31, 2025, Bunge Global SA (NYSE: BG) disclosed that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V. (2026, 2027, 2031 and 2032 notes) from February 3, 2025 to March 7, 2025. The exchange offers allow holders to swap Viterra notes for new BLFC notes guaranteed by Bunge, capped at $1.95 billion aggregate principal, plus cash. The transaction is tied to Bunge's pending acquisition of Viterra, which is conditioned on antitrust approvals and customary closing conditions, and the company expects to close in the next several months. The extension was needed because the acquisition had not yet closed; BLFC has said it will keep extending the expiration date until the deal can be consummated on or before the expiration date. As of 5:00 a.m. ET on January 31, 2025, holders had tendered very high proportions of each series: about 96.4% of the 2026 notes, 97.4% of the 2027 notes, 99.3% of the 2031 notes and 98.4% of the 2032 notes. Consents previously delivered remain valid, and the supplemental indentures executed September 23, 2024 will only become operative at settlement, expected within two business days after the expiration date. The Proposed Amendments would strip most covenants and events of default and release the Viterra and Viterra B.V. guarantees, which substantially reduces protection for any holders who do not exchange. For investors, the filing is primarily a procedural update, but it signals that the Viterra acquisition timeline has slipped beyond the original February date and that Bunge is consolidating Viterra's debt into its own credit. Holders of unexchanged Viterra notes face reduced liquidity and weaker protections, while Bunge's obligations would increase through the new guaranteed notes. Investors should watch for antitrust clearance and any further extensions.

Jan 31, 2025 8-K

Bunge Global 8-K Report, Corporate Update (Dec 30, 2024)

On December 30, 2024, Bunge Global SA (NYSE: BG) disclosed that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V. (VFBV) to 5:00 p.m. New York City time on February 3, 2025, from January 2, 2025. The offers cover the 2.000% Notes due 2026, 4.900% Notes due 2027, 3.200% Notes due 2031 and 5.250% Notes due 2032, exchangeable for up to $1.95 billion of new BLFC notes guaranteed by Bunge, plus cash. The transaction is tied to Bunge's pending acquisition of Viterra, and BLFC has stated it expects to keep extending the deadline until that deal closes if it is not anticipated to close by the expiration date. The consent solicitations seek to strip covenants, restrictive provisions and certain events of default from the existing Viterra indentures, and to release the Viterra and Viterra B.V. guarantees. Consents were sufficient at the September 20, 2024 early tender deadline, and the supplemental indentures were executed September 23, 2024, but the amendments only become operative at settlement, expected within two business days after the expiration date. Tender participation as of 5:00 a.m. on December 30, 2024 was high: 95.8% of the 2026 notes, 97.3% of the 2027 notes, 99.3% of the 2031 notes and 98.3% of the 2032 notes had been validly tendered. For investors, the filing mainly signals that Bunge is consolidating Viterra's debt into its own credit structure, with the Bunge guarantee replacing Viterra's guarantees. Holders who do not exchange will be left with notes that have fewer protections and reduced liquidity. Bunge stated the regulatory approval process is progressing and that it expects to close the Viterra acquisition within the next several months. Closing is subject to antitrust approvals and other customary conditions, and is not conditioned on the exchange offers or on financing.

Dec 30, 2024 8-K

Bunge Global 8-K Report, Bylaw Amendment (Dec 9, 2024)

Bunge Global SA (BG) filed an 8-K on December 9, 2024, primarily detailing an amendment to its Articles of Association concerning a reduction in share capital. Effective December 6, 2024, the Company reduced its share capital by USD 61,469.30, bringing the total to USD 1,552,825.42. This reduction stems from the cancellation of 6,146,930 treasury shares, which were previously repurchased under the company's share buyback program. Concurrently, Article 4a of the Articles of Association was updated to reflect this change in the Swiss "capital band" provision.

Dec 9, 2024 8-K

Bunge Global 8-K Report, Material Agreement (Dec 5, 2024)

Bunge Global SA (BG) announced on December 5, 2024, that it has amended its existing trade receivables securitization program. The key change involves extending the termination date of this program by an additional 364 days, pushing it to December 16, 2025. This extension is significant as it provides Bunge with continued access to a crucial source of short-term financing through the sale of its trade receivables. While the amendment primarily focuses on extending the program's term, other material terms and conditions remain unchanged. The securitization program allows Bunge to convert its accounts receivable into cash, which can support working capital needs and operational flexibility. The filing also confirms that Bunge and its subsidiaries are obligated to repurchase ineligible receivables, and recourse beyond a first-loss position is limited, which is standard for such arrangements. Investors should view this as a positive development for maintaining liquidity and financial stability.

Dec 5, 2024 8-K

Bunge Global 8-K Report, Corporate Update (Nov 15, 2024)

On November 15, 2024, Bunge Global SA (NYSE: BG) disclosed that its Board of Directors on November 13, 2024 authorized an additional $500 million share repurchase under its existing program first authorized June 13, 2023. Combined with approximately $800 million remaining under that program as of September 30, 2024, the expanded program provides aggregate repurchase authorization of roughly $1.3 billion. The program has an indefinite term and may be executed through open market purchases, privately negotiated transactions, or Rule 10b5-1 trading plans, and may be modified, suspended, or discontinued at any time without notice. The CEO, Greg Heckman, linked the expansion to proceeds from the sale of Bunge's interest in its sugar and bioenergy joint venture, positioning buybacks as a component of the company's capital allocation framework. For investors, the key takeaway is that a meaningful portion of divestiture proceeds is being returned to shareholders, which signals management's view that the shares are an attractive use of capital, though the filing does not commit to a specific pace or total amount of repurchases. The filing is largely a disclosure of authorization rather than a change in financial results. Investors should weigh the buyback capacity against the forward-looking risks flagged in the release, including commodity and crop cycles, regulatory and trade policy, and the pending business combination with Viterra Limited, which may affect how much capital the company ultimately deploys toward repurchases.

Nov 15, 2024 10-Q

Bunge Global Quarterly Report for Q3 Ended Sep 30, 2024

Bunge Global SA reported a significant decrease in net income for the nine months ended September 30, 2024, with net income attributable to Bunge shareholders at $535 million, a substantial drop from $1,627 million in the same period last year. This decline is primarily attributed to lower gross profit in the Agribusiness segment and reduced performance across both Core and Non-core segments. Diluted earnings per share also saw a considerable decrease to $3.73 from $10.71 year-over-year. The company is actively navigating the complex regulatory and financing landscape surrounding its pending acquisition of Viterra, having secured significant debt financing and issued new senior notes. Bunge also completed the divestiture of its 50% stake in BP Bunge Bioenergia. Despite the overall decrease in profitability, the company maintained a strong liquidity position, with cash and cash equivalents increasing to $2,836 million. Investors should monitor the progress and impact of the Viterra acquisition and the company's efforts to manage commodity price volatility.

Oct 30, 2024